Letter From The Editor

Last week I was in the checkout lane at a grocery store and noticed how many magazines there were for diabetes and weight loss. It seems that almost every one of the headlines had something to do with eating more fat to lose weight. I looked at the articles and …

For 20 years, we at Diabetes in Control have attended the ADA Scientific Sessions. Each year there are great research presentations and these always include two topics: the artificial pancreas and the cure for type 1 diabetes. Most of the time what was the latest and greatest the previous year …

This past week, the U.S. Supreme Court decided that federal exchanges for the Affordable Care Act were in accordance with the guidelines of the Act and millions of patients will be able to still have healthcare that otherwise would be left out. It has been an interesting couple of months …

Sometimes clinicians focus on things that we would not expect. Last week we had a little bit of information in our Homerun Slides about pramlintide. The response to these slides actually caught us by surprise and so this week we have dedicated all the slides to pramlintide and how best …

There has been a lot of press and discussion about using SGLT-2 inhibitors in type 1 diabetes due to the risk of DKA. Many of these articles focused on what happened to patients when they got DKA and whether it could be shown if the relationship was causal or causative. When …

When we were reviewing the data and presentations from the recent ADA Scientific Sessions we were commenting on how often a study comes out at this meeting that lends credibility to what you are already doing. This week we have a new study that talks about using triple therapy in …

When a new idea comes along in medicine usually the clinician who first came up with the idea is ostracized by his or her less adventerous colleagues. There is nowhere this is more obvious than in the diabetes arena. One of our board members, Dr. Richard Bernstein, turned 81 today. …

This morning I had a new PharmD candidate start a rotation with me. As is customary with all my interns, I spent the first few hours getting them out of "textbook/multiple choice" mode and into "patient care" mode. During the conversation I often pick one drug and we have a …

One of the best things that happens at the ADA is the chance to interact with our Advisory Board members. When Steve and I started this publication 15 years ago, we were able to win readers with our unique style of presenting the news. Along the way we have become …

We’ve been at the ADA Scientific Sessions in Boston for the last four days where we garnered more than 20 interviews with top thinkers in diabetes. We will be bringing you this great information over the next few months. One of our favorite interviewees is always Dr. Aaron Vinik, who …